Health
Sequencing Study from Roswell Park Highlights Previously Unknown Myeloma Resistance Mechanisms – Newswise
— A group of researchers led by Maximillian Merz, MD, Assistant Professor of Oncology with the Myeloma team at Roswell Park Comprehensive Cancer Center, condu
- First single-cell analysis in a prospective trial for patients with myeloma
- Plasma-cell clones responsible for characteristic bone lesions, team shows
- Findings suggest new strategies for eradicating minimal residual disease
Newswise — BUFFALO, N.Y. — A group of researchers led by Maximillian Merz, MD, Assistant Professor of Oncology with the Myeloma team at Roswell Park Comprehensive Cancer Center, conducted the first prospective clinical trial investigating spatial heterogeneity in patients with either…
Continue Reading
-
General23 hours agoAustralian economy still vulnerable to US bond turmoil
-
General9 hours agoDemocratic senators want an investigation into potential market manipulation from Trump’s inner circle
-
Business19 hours agoWhat I’d buy before the ASX rebounds: 3 high-conviction share picks
-
Noosa News8 hours agoMotorbike rider dies after car collision at Kidaman Creek, west of Sunshine Coast